P. Kouides

发表

PNEUMOCYSTIS CARINII PNEUMONIA AS A COMPLICATION OF DESFERRIOXAMINE THERAPY

C. Slapak, P. Kouides, L. Rosenwasser, 1988, British journal of haematology.

Prospective analysis of bleeding events in left ventricular assist device patients

C. Lowenstein, P. Kouides, H. Massey, 2018, The International journal of artificial organs.

Platelet function testing: state of the art

P. Kouides, A. Zeidan, Mary Ann Tara, 2007, Expert review of cardiovascular therapy.

Hemostatic efficacy, safety, and pharmacokinetics of a recombinant von Willebrand factor in severe von Willebrand disease.

J. Gill, G. Castaman, P. Kouides, 2015, Blood.

Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors

J. Douketis, T. Ortel, P. Kouides, 2012, American journal of hematology.

Hormonal influences on hemostasis in women.

P. Kouides, M. Wood, D. E. Trigg, 2011, Seminars in thrombosis and hemostasis.

Inherited Bleeding Disorders in Women

Christine A. Lee, P. Kouides, R. Kadir, 2009 .

How do we treat: upper gastrointestinal bleeding in adults with haemophilia

P. Kouides, P. Fogarty, 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

von Willebrand disease in the pediatric and adolescent population.

S. Mikhail, P. Kouides, 2010, Journal of pediatric and adolescent gynecology.

Disorders of hemostasis and excessive menstrual bleeding: prevalence and clinical impact.

P. Kouides, F. Peyvandi, R. Kadir, 2005, Fertility and sterility.

VAD-t (Vincristine, Adriamycin, Dexamethasone and Low-Dose Thalidomide) Is an Effective Initial Therapy with High Response Rates for Patients with Treatment Naïve Multiple Myeloma (MM).

Arif Alam, M. Czuczman, A. Chanan-Khan, 2004 .

Outcomes of long‐term von Willebrand factor prophylaxis use in von Willebrand disease: A systematic literature review

R. Mustafa, A. Tosetto, M. Laffan, 2022, Haemophilia : the official journal of the World Federation of Hemophilia.

Evaluation and management of postpartum hemorrhage: consensus from an international expert panel

J. Herman, S. Hofer, P. Kouides, 2014, Transfusion.

Anti fi brinolytic therapy for preventing VWD-related postpartum hemorrhage : indications and limitations

P. Kouides, Mary M. Gooley, 2017 .

Antifibrinolytic therapy for preventing VWD-related postpartum hemorrhage: indications and limitations.

P. Kouides, 2017, Blood advances.

Present day management of inherited bleeding disorders in pregnancy

P. Kouides, 2016, Expert review of hematology.

Preventing postpartum haemorrhage‐when guidelines fall short

P. Kouides, 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

An update on the management of bleeding disorders during pregnancy

P. Kouides, 2015, Current opinion in hematology.

Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel.

P. Kamphuisen, B. Konkle, P. Kouides, 2009, American journal of obstetrics and gynecology.

Evaluation and management of acute menorrhagia in women with and without underlying bleeding disorders: consensus from an international expert panel.

Christine A. Lee, P. Kamphuisen, P. Kouides, 2011, European journal of obstetrics, gynecology, and reproductive biology.

Standardizing care to manage bleeding disorders in adolescents with heavy menses—A joint project from the ISTH pediatric/neonatal and women's health SSCs

M. Othman, Dmitry Khodyakov, P. Kouides, 2020, Journal of thrombosis and haemostasis : JTH.

Multisite management study of menorrhagia with abnormal laboratory haemostasis: a prospective crossover study of intranasal desmopressin and oral tranexamic acid

N. Dowling, J. Heit, B. Evatt, 2009, British journal of haematology.

Defining Minimum Necessary Anticoagulation-Related Communication at Discharge: Consensus of the Care Transitions Task Force of the New York State Anticoagulation Coalition.

P. Kouides, P. Meek, J. Ansell, 2018, Joint Commission journal on quality and patient safety.

Adolescent Pregnancy Complicated by Thrombosis

P. Kouides, C. Dersch, 2020 .

Antifibrinolytics: Indications and Precautions

P. Kouides, M. Harthy, 2016 .

Ledipasvir–sofosbuvir and sofosbuvir plus ribavirin in patients with chronic hepatitis C and bleeding disorders

P. Sax, K. Reddy, K. Workowski, 2017, Haemophilia : the official journal of the World Federation of Hemophilia.

A Benefit-Risk Review of Systemic Haemostatic Agents

I. Fraser, R. Porte, P. Kouides, 2008, Drug safety.

A Benefit-Risk Review of Systemic Haemostatic Agents

I. Fraser, R. Porte, P. Kouides, 2008, Drug safety.

Diagnosis and management of heparin-induced thrombocytopenia

P. Kouides, W. Fricke, 2005, Expert review of cardiovascular therapy.

Bleeding Disorders in Pregnancy

P. Kouides, Maissaa Janbain, M. Janbain, 2020, Hematology in the Adolescent Female.

Prospective evaluation of ISTH‐BAT as a predictor of bleeding disorder in adolescents presenting with heavy menstrual bleeding in a multidisciplinary hematology clinic

Song Zhang, P. Kouides, A. Zia, 2020, Journal of thrombosis and haemostasis : JTH.

Evolution of replacement therapy for von Willebrand disease: From plasma fraction to recombinant von Willebrand factor.

P. Kouides, F. Peyvandi, E. Berntorp, 2019, Blood reviews.

Feasibility of the Von Willebrand disease PREVENT trial.

A. Neff, C. Kessler, B. Konkle, 2017, Thrombosis research.

von Willebrand Disease: Prevention of Complications and Management of the Disease

P. Kouides, 2016 .

Women with von Willebrand Disease

Christine A. Lee, P. Kouides, R. Kadir, 2011 .

Women and Von Willebrand Disease

P. Kouides, 2010 .

Bleeding symptom assessment and hemostasis evaluation of menorrhagia

P. Kouides, 2008, Current opinion in hematology.

Gynaecological and obstetrical morbidity in women with type I von Willebrand disease: results of a patient survey

F. Howard, P. Kouides, P. Phatak, 2000, Haemophilia : the official journal of the World Federation of Hemophilia.

Obstetric and gynaecological aspects of von Willebrand disease.

P. Kouides, Peter A. Kouides, 2001, Best practice & research. Clinical haematology.

Females with von Willebrand disease: 72 years as the silent majority

C. Kessler, P. Kouides, U. Martinowitz, 1998, Haemophilia : the official journal of the World Federation of Hemophilia.

Endometrial ablation for von Willebrand disease‐related menorrhagia – experience with seven cases

P. Kouides, G. Rubin, M. Wortman, 2004, Haemophilia : the official journal of the World Federation of Hemophilia.

A presumed case of Darbepoetin‐induced myocardial infarction in the patient with MDS‐RARS

P. Kouides, A. Zafar, 2020, Clinical case reports.

Cytarabine-induced pericarditis: a case report and review of the literature of the cardio-pulmonary complications of cytarabine therapy.

P. Kouides, R. Sham, S. Reykdal, 1995, Leukemia research.

von Willebrand disease: proposing definitions for future research.

R. Mustafa, M. Ozelo, S. O’Brien, 2021, Blood advances.

Allergic reactions to cyclophosphamide: delayed clinical expression associated with positive immediate skin tests to drug metabolites in five patients.

J. Leddy, P. Kouides, J. Condemi, 1996, The Journal of allergy and clinical immunology.

Complications of Venous Thromboembolic Disease

P. Kouides, G. Connolly, 2016 .

Surgical management of patients with von Willebrand disease: summary of 2 systematic reviews of the literature

R. Mustafa, S. O’Brien, A. Tosetto, 2021, Blood advances.

Efficacy and Safety of Direct Oral Anticoagulants in Venous Thromboembolism Compared to Traditional Anticoagulants in Morbidly Obese Patients: A Systematic Review and Meta-Analysis

R. Pathak, P. Kouides, M. Aryal, 2021, Cureus.

Venous Thromboembolism in COVID-19: Towards an Ideal Approach to Thromboprophylaxis, Screening, and Treatment

V. Bhatt, R. Pathak, P. Kouides, 2020, Current Cardiology Reports.

Aspects of the laboratory identification of von Willebrand disease in women.

P. Kouides, 2006, Seminars in thrombosis and hemostasis.

Systematic review and meta-analysis of the efficacy and safety of apixaban compared to rivaroxaban in acute VTE in the real world.

P. Kouides, A. Donato, M. Aryal, 2019, Blood advances.

Gynecologic and obstetric management of women with von Willebrand disease: summary of 3 systematic reviews of the literature

R. Mustafa, M. Ozelo, P. James, 2021, Blood advances.

The scope and value of an anticoagulation stewardship program at a community teaching hospital

P. Kouides, C. Ruscio, R. Sham, 2017, Journal of Thrombosis and Thrombolysis.

Metachronous development of nonamyloidogenic [lambda] light chain deposition disease and IgG heavy chain amyloidosis in the same patient.

P. Kouides, T. Nadasdy, M. Grieff, 2003, The American journal of surgical pathology.

Rituximab-induced leukocytoclastic vasculitis: a case report.

P. Kouides, P. Kandula, 2006, Archives of dermatology.

Rare Coagulation Factor Deficiencies (Factors VII, X, V, and II).

P. Kouides, G. Batsuli, 2021, Hematology/oncology clinics of North America.

Transformation of chronic myelomonocytic leukemia to acute lymphoblastic leukemia: Case report and review of the literature of lymphoblastic transformation of myelodysplastic syndrome

P. Kouides, J. Bennett, 1995, American journal of hematology.

Advances in the therapy of the myelodysplastic syndromes.

J. Bennett, P. Kouides, 1999, Cancer treatment and research.

Menorrhagia from a haematologist's point of view. Part II: management

P. Kouides, J. Siegel, 2002, Haemophilia : the official journal of the World Federation of Hemophilia.

Diagnosis and treatment of inherited factor X deficiency

P. Kouides, D. Brown, Deborah L Brown, 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

Management of anticoagulation associated reproductive tract bleeding in adolescent and young adult females - Results of a multinational survey.

S. O’Brien, P. Kouides, A. Zia, 2021, Thrombosis research.

Impact of obesity on factor VIII and von Willebrand factor levels in patients with Type 1 von Willebrand disease and low von Willebrand factor: An analysis of the ATHNdataset

P. Kouides, D. Cheng, B. Schaefer, 2021, Haemophilia : the official journal of the World Federation of Hemophilia.

Primary thromboprophylaxis in a patient with type 3 von Willebrand disease and severe COVID‐19 infection

Joseph J. Stanco, P. Kouides, S. Acharya, 2021, Haemophilia : the official journal of the World Federation of Hemophilia.

Chronic therapeutic anticoagulation is associated with decreased thrombotic complications in SARS‐CoV‐2 infection

P. Kouides, P. Prasad, R. White, 2020, Journal of Thrombosis and Haemostasis.

Pathology of Thrombotic Thrombocytopenic Purpura in the Placenta, with Emphasis on the “Snowman Sign”

P. Kouides, S. Cramer, R. Sham, 2007, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

Isocitrate dehydrogenase mutation and risk of venous thromboembolism in glioma: A systematic review and meta-analysis.

P. Kouides, S. K. Low, Z. Anjum, 2022, Thrombosis research.

Approach to the Patient with an Inherited Bleeding Disorder

P. Kouides, C. Philipp, 2009 .

Von Willebrand Disease and other Disorders of Hemostasis in the Patient with Menorrhagia

P. Kouides, 2005, Women's health.

Screening for von Willebrand disease in children: a case–control study

C. Kempton, P. Kouides, M. Ragni, 2011, Journal of thrombosis and haemostasis : JTH.

Safe and Effective Use of Chronic Transdermal Estradiol for Life-Threatening Uremic Bleeding in a Patient with Coronary Artery Disease

P. Kouides, J. Hix, Atul Bali, 2014, Nephron Extra.

Near‐fatal uterine hemorrhage during induction chemotherapy for acute myeloid leukemia: A case report of bilateral uterine artery embolization

P. Kouides, J. Broder, J. Phelan, 2004, American journal of hematology.

The use of a single von Willebrand factor‐containing, plasma‐derived FVIII product in hemophilia A immune tolerance induction: the US experience

J. Puetz, E. Neufeld, D. Quon, 2011, Journal of thrombosis and haemostasis : JTH.

Hepatosplenic T-cell lymphoma in a patient with Crohn's disease who received infliximab therapy

P. Kouides, A. Zeidan, J. Shapiro, 2007, Leukemia & lymphoma.

Managing Pregnant Women with Hemophilia and von Willebrand Disease: How Do We Provide Optimum Care and Prevent Complications?

P. Kouides, M. Janbain, 2022, International journal of women's health.

Emerging clinical concerns in the ageing haemophilia patient

C. Kessler, D. Quon, B. Konkle, 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

How we manage prostate biopsy and prostate cancer therapy in men with haemophilia

P. Kouides, P. Fogarty, 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

Bleeding disorders in adolescents with heavy menstrual bleeding in a multicenter prospective US cohort

Song Zhang, P. Kouides, A. Zia, 2019, Haematologica.

Arthroplasty in haemophilia: Double‐edged sword in low/middle‐income countries

P. Kouides, A. Forsyth, L. Solimeno, 2020, Haemophilia : the official journal of the World Federation of Hemophilia.

Prophylaxis in severe forms of von Willebrand's disease: results from the von Willebrand Disease Prophylaxis Network (VWD PN)

P. Mannucci, M. Makris, J. Cox Gill, 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

Prophylactic treatment of severe factor X deficiency with prothrombin complex concentrate

P. Kouides, L. Kulzer, 2001, Haemophilia : the official journal of the World Federation of Hemophilia.

Intracranial haemorrhage among a population of haemophilic patients in Nepal: Challenges and future direction

P. Kouides, Bishesh Sharma Poudyal, Nira Neupane, 2021, Haemophilia.

How we treat: patients with haemophilia undergoing screening colonoscopy

P. Kouides, P. Fogarty, 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

A multicenter clinical evaluation of the Clot Signature Analyzer

A. Schmaier, P. Kouides, K. Jagadeesan, 2004, Journal of thrombosis and haemostasis : JTH.

Management of excessive menstrual bleeding in women with hemostatic disorders.

J. Goudemand, P. Kouides, R. Kadir, 2005, Fertility and sterility.

A benefit-risk review of systemic haemostatic agents: part 2: in excessive or heavy menstrual bleeding.

I. Fraser, R. Porte, P. Kouides, 2008 .

Menorrhagia associated with laboratory abnormalities of hemostasis: epidemiological, diagnostic and therapeutic aspects

P. Kouides, R. Kadir, R. Kadir, 2007, Journal of thrombosis and haemostasis : JTH.

A cross-sectional analysis of cardiovascular disease in the hemophilia population.

C. Leissinger, C. Kempton, C. Kessler, 2018, Blood advances.

Regulation and importance of factor VIII levels in hemophilia A carriers

P. Kouides, P. Cygan, 2021, Current opinion in hematology.

Occurrence rates of von Willebrand disease among people receiving care in specialized treatment centres in the United States

P. Kouides, V. Byams, C. Miller, 2021, Haemophilia : the official journal of the World Federation of Hemophilia.

Prophylaxis escalation in severe von Willebrand disease: a prospective study from the von Willebrand Disease Prophylaxis Network

C. Kempton, M. Carcao, F. Leebeek, 2015, Journal of thrombosis and haemostasis : JTH.

Surgical excision of a pseudotumour under the coverage of the plasma‐derived factor X concentrate in a patient with severe factor X deficiency: A case report

P. Kouides, A. Forsyth, L. Solimeno, 2021, Haemophilia : the official journal of the World Federation of Hemophilia.

Developing a multidisciplinary Young Women's Blood Disorders Program: a single‐centre approach with guidance for other centres

P. Kouides, J. Journeycake, A. Zia, 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

The impact of extended half‐life factor concentrates on prophylaxis for severe hemophilia in the United States

M. Recht, C. Witmer, P. Kouides, 2020, American journal of hematology.

Changes in bleeding patterns in von Willebrand disease after institution of long-term replacement therapy: results from the von Willebrand Disease Prophylaxis Network

P. Mannucci, L. Valentino, C. Kempton, 2015, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

A Morphometric Analysis of Platelet Dense Granules of Patients with Unexplained Bleeding: A New Entity of Delta-Microgranular Storage Pool Deficiency

J. Turner, P. Kouides, W. Gunning, 2020, Journal of clinical medicine.

Use of donated clotting factors for surgeries on haemophilic patients in a resource‐constrained country: a kind donor, good outcome, change of practice and future directions

B. Gyawali, G. Shrestha, P. Kouides, 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

Regional variation and cost implications of prescribed extended half‐life factor concentrates among U.S. Haemophilia Treatment Centres for patients with moderate and severe haemophilia

E. Neufeld, C. Thornburg, P. Kouides, 2019, Haemophilia : the official journal of the World Federation of Hemophilia.

A new hemophilia carrier nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH

M. Othman, J. Mahlangu, P. James, 2021, Journal of thrombosis and haemostasis : JTH.

The spectrum of bleeding in women and girls with haemophilia B

J. Staber, E. Grabowski, P. Kouides, 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

your lab focus: CE update [blood banking/transfusion medicine | hematology | microbiology and virology]: Viral Safety Of Plasma Products

P. Kouides, W. Fricke, 2003 .

Challenges of rare disease research: limited patients and competing priorities

C. Francis, N. Key, P. Kouides, 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

Current understanding of von Willebrand's disease in women – some answers, more questions

P. Kouides, 2006, Haemophilia : the official journal of the World Federation of Hemophilia.

ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease.

R. Mustafa, M. Ozelo, S. O’Brien, 2021, Blood advances.

Safety of a pasteurized plasma‐derived Factor VIII and von Willebrand factor concentrate: analysis of 33 years of pharmacovigilance data

T. Simon, H. Mead, P. Kouides, 2017, Transfusion.

Von Willebrand factor for menorrhagia: a survey and literature review

A. Neff, C. Kessler, B. Konkle, 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

A cross-sectional analysis of cardiovascular disease in the hemophilia population.

C. Leissinger, C. Kempton, A. Neff, 2014, Blood advances.

Surveillance of female patients with inherited bleeding disorders in United States Haemophilia Treatment Centres

B. Konkle, J. Gill, P. Kouides, 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

Menorrhagia from a haematologist's point of view. Part I: initial evaluation

P. Kouides, Peter A. Kouides, 2002, Haemophilia : the official journal of the World Federation of Hemophilia.

Postpartum von Willebrand factor levels in women with and without von Willebrand disease and implications for prophylaxis

B. Konkle, P. Kouides, A. James, 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

The diagnosis, natural history, and management of von Willebrand disease in women in the age of guidelines

P. Kouides, Sanjana Kalvehalli Kashinath, 2023, Expert review of hematology.

Comprar Inherited Bleeding Disorders in Women | Ronald Grooters | 9781405169158 | Wiley

Christine A. Lee, P. Kouides, R. Kadir, 2009 .

Recombinant von Willebrand factor: a first-of-its-kind product for von Willebrand disease.

P. Kouides, M. Singal, 2016, Drugs of today.

Laboratory misdiagnosis of von Willebrand disease in post‐menarchal females: A multi‐center study

J. Staber, S. O’Brien, P. Kouides, 2020, American journal of hematology.

Low von Willebrand Factor in Children and Adolescents: A Review.

P. Kouides, L. Srivaths, 2021, JAMA pediatrics.

The spectrum and severity of bleeding in adolescents with low von Willebrand factor-associated heavy menstrual bleeding.

S. O’Brien, C. Minard, P. Kouides, 2020, Blood advances.

The prevalence of disorders of haemostasis in adolescents with menorrhagia referred to a haemophilia treatment centre

S. Mikhail, P. Kouides, R. Varadarajan, 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

Evaluation of a screening tool for bleeding disorders in a US multisite cohort of women with menorrhagia.

Ambarina S. Faiz, J. Heit, P. Kouides, 2011, American journal of obstetrics and gynecology.

The spectrum of haemostatic characteristics of women with unexplained menorrhagia

N. Dowling, J. Heit, P. Kouides, 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

Validation Study of the Composite Score to Identify Von Willebrand Disease in Children

C. Moore, B. Kerlin, C. Witmer, 2013, Journal of pediatric hematology/oncology.

When age is truly only a number: late diagnosis of von Willebrand disease type 2B in a 61-year-old woman.

P. Kouides, M. Singal, 2019, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Evaluation of abnormal bleeding in women.

P. Kouides, 2002, Current hematology reports.

Hemostasis and menstruation: appropriate investigation for underlying disorders of hemostasis in women with excessive menstrual bleeding.

P. Kouides, F. Peyvandi, R. Kadir, 2005, Fertility and sterility.

Differences in bleeding phenotype and provider interventions in postmenarchal adolescents when compared to adult women with bleeding disorders and heavy menstrual bleeding

P. Kouides, A. James, V. Byams, 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

Does a Bleeding Disorder Lessen the Efficacy of the 52-mg Levonorgestrel-Releasing Intrauterine System for Heavy Menstrual Bleeding in Adolescents? A Retrospective Multicenter Study.

P. Kouides, A. Weyand, M. Baldwin, 2022, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

Provider Attitudes and Practices Regarding IUS Insertion in Adolescents With and Without Bleeding Disorders for Management of Heavy Menstrual Bleeding

P. Kouides, K. Haley, A. Wheeler, 2021, Journal of Pediatric and Adolescent Gynecology.

YNECOLOGY on Willebrand disease and other bleeding isorders in women : Consensus on diagnosis and anagement from an international expert panel

P. Kamphuisen, B. Konkle, P. Kouides, 2022 .

Flutamide‐induced cyanosis refractory to methylene blue therapy

C. Abboud, P. Kouides, V. Fairbanks, 1996, British journal of haematology.

Large granular lymphocyte leukemia presenting with both amegakaryocytic thrombocytopenic purpura and pure red cell aplasia: Clinical course and response to immunosuppressive therapy

J. Rowe, P. Kouides, P. Kouides, 1995, American journal of hematology.

Morphology and classification of myelodysplastic syndromes.

J. Bennett, P. Kouides, 1992, Hematology/oncology clinics of North America.

Update on perioperative bridging in patients on chronic oral anticoagulation

B. Faltas, P. Kouides, 2009, Expert review of cardiovascular therapy.

Rare case of hemolytic uremic syndrome associated with only one transient low platelet count

P. Kouides, K. Hatti, M. Rojas, 2012, Journal of Hematopathology.

Morphology and classification of the myelodysplastic syndromes and their pathologic variants.

J. Bennett, P. Kouides, John M. Bennett, 1996, Seminars in hematology.

Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in a postpartum patient with preeclampsia: a case report

P. Kouides, Bruce Lee, Stephanie Bousquet, 2021, AJOG global reports.

Risk of second primary malignancy in patients with primary myelofibrosis: a SEER database study

V. Bhatt, P. Kouides, S. Gaire, 2022, Leukemia & lymphoma.

The Myelodysplastic Syndromes: Morphology, risk assessment, and clinical management (2002)

J. Bennett, S. Forman, P. Kouides, 2002, International journal of hematology.

Dabigatran-Induced Gastrointestinal Bleeding in an Elderly Patient with Moderate Renal Impairment

P. Kouides, M. K. Wychowski, 2012, The Annals of pharmacotherapy.

Hematologic neoplasia and the central nervous system

V. Marder, P. Kouides, P. Phatak, 1999, American journal of hematology.

Cardiac ALL: Most Unusual Occurrence of Lenalidomide-associated Acute Lymphoblastic Leukemia with Subsequent Cardiac Involvement

P. Kouides, H. Hassoun, J. Hatem, 2019, Cureus.

Systemic mastocytosis: a concise clinical and laboratory review.

A. Tefferi, M. Patnaik, P. Kouides, 2007, Archives of pathology & laboratory medicine.

Transient Decrease in Factor VIII Following Delivery: Clearance or Consumption?

B. Konkle, P. Kouides, A. James, 2011 .

The Relationship between Heavy Menstrual Bleeding, Iron Deficiency, and Iron Deficiency Anemia.

M. Munro, S. O’Brien, P. Kouides, 2023, American journal of obstetrics and gynecology.

Whole-exome analysis of adolescents with low VWF and heavy menstrual bleeding identifies novel genetic associations

S. O’Brien, J. Di Paola, C. Minard, 2021, Blood advances.

Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for mucocutaneous bleeding disorders

B. Konkle, J. Di Paola, K. Neeves, 2023, Expert review of hematology.

Outgrowing the laboratory diagnosis of type 1 von Willebrand disease: A two decade study

M. Secic, P. Kouides, Gbolahan O. Ogunbayo, 2018, American journal of hematology.

Tranexamic Acid: A Novel Oral Formulation for the Treatment of Heavy Menstrual Bleeding

P. Kouides, A. Lukes, Keith A. Moore, 2011, Women's Health.

All catastrophes are not catastrophic antiphospholipid syndrome

P. Kouides, M. Singal, 2022, American journal of hematology.

Approach to the patient with aninherited bleeding disorder

P. Kouides, C. Philipp, 2022 .

6B.1 Menorrhagia and von Willebrand disease

P. Kouides, 2007 .

B-cell acute lymphoblastic leukemia with L1 morphology and coexistence of t(1;19) and t(14;18) chromosome translocations.

J. Bennett, P. Kouides, P. Phatak, 1994, Cancer genetics and cytogenetics.

Effectiveness of intravenous immunoglobulin use in heparin-induced thrombocytopenia.

P. Kouides, A. Donato, M. Aryal, 2020, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Features of Electronic Health Records Necessary for the Delivery of Optimized Anticoagulant Therapy

P. Kouides, J. Ansell, Jack Ansell, 2015, The Annals of pharmacotherapy.

Dose effect and efficacy of rFVIIa in the treatment of haemophilia patients with inhibitors: analysis from the Hemophilia and Thrombosis Research Society Registry

P. Marks, A. Angiolillo, L. Valentino, 2005, Haemophilia : the official journal of the World Federation of Hemophilia.

Depression and anxiety in persons with Von Willebrand disease

M. Nichol, Joanne Wu, B. Konkle, 2021, Haemophilia : the official journal of the World Federation of Hemophilia.

Understanding the Myelodysplastic Syndromes.

J. Bennett, P. Kouides, Bennett, 1997, The oncologist.

Hepatitis B reactivation following allogeneic bone marrow transplantation: case report and review of the literature.

J. Dipersio, J. Rowe, P. Kouides, 1995, Bone marrow transplantation.

One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: value of pretransplant disease status for predicting outcome.

M. A. Tanner, J. Liesveld, C. Abboud, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Predictors of Von Willebrand Disease In Children: A Case-Control Study

C. Kempton, P. Kouides, M. Ragni, 2010 .

Patients > or = age 40 years undergoing autologous or allogeneic BMT have regimen-related mortality rates and event-free survivals comparable to patients < age 40 years.

J. Dipersio, M. A. Tanner, L. Constine, 1995, Bone marrow transplantation.

von Willebrand disease in the pediatric and adolescent population.

S. Mikhail, P. Kouides, 2010, Journal of pediatric and adolescent gynecology.

Efficacy and safety of half‐dose desmopressin for bleeding prophylaxis in bleeding disorder patients undergoing predominantly low to moderate risk invasive procedures

P. Kouides, F. Furqan, R. Sham, 2020 .

Hemostatic efficacy, safety, and pharmacokinetics of a recombinant von Willebrand factor in severe von Willebrand disease.

J. Gill, G. Castaman, P. Kouides, 2015, Blood.

Evaluation of a screening tool for bleeding disorders in a US multisite cohort of women with menorrhagia.

Ambarina S. Faiz, J. Heit, P. Kouides, 2011, American journal of obstetrics and gynecology.

Is ≥ 100% the magic number to rule out the laboratory diagnosis of von Willebrand disease based on initial testing?

P. Kouides, J. Jaffray, J. Malvar, 2021, American journal of hematology.

Evaluation and management of acute menorrhagia in women with and without underlying bleeding disorders: consensus from an international expert panel.

Christine A. Lee, P. Kamphuisen, P. Kouides, 2011, European journal of obstetrics, gynecology, and reproductive biology.

Bleeding symptoms and laboratory correlation in patients with severe von Willebrand disease

R. Watts, E. Kraut, B. Kerlin, 2009, Haemophilia.

Features of Electronic Health Records Necessary for the Delivery of Optimized Anticoagulant Therapy

P. Kouides, J. Ansell, A. Spyropoulos, 2015, The Annals of pharmacotherapy.

Depression and anxiety in persons with Von Willebrand disease

M. Nichol, Joanne Wu, B. Konkle, 2022, Haemophilia.

Healthcare Utilization and Health Related Quality of Life in Persons with Von Willebrand Disease

M. Nichol, Joanne Wu, B. Konkle, 2020 .

Hysterectomy versus expanded medical treatment for abnormal uterine bleeding: clinical outcomes in the medicine or surgery trial.

P. Kouides, A. Lukes, 2004, Obstetrics and gynecology.

Systemic mastocytosis: a concise clinical and laboratory review.

A. Tefferi, M. Patnaik, P. Kouides, 2007, Archives of pathology & laboratory medicine.